These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 143293)

  • 41. [Comparison of the therapeutic effect of Atrovent inhalations with an oral antiasthmatic agent].
    Feldner H
    Wien Med Wochenschr; 1976 Jun; 126(23):332-5. PubMed ID: 10682
    [No Abstract]   [Full Text] [Related]  

  • 42. The pulmonary hemodynamic effects of aerosols of isoproterenol and ipratropium in normal subjects and patients with reversible airway obstruction.
    Sackner MA; Friedman M; Silva G; Fernandez R
    Am Rev Respir Dis; 1977 Dec; 116(6):1013-22. PubMed ID: 145195
    [No Abstract]   [Full Text] [Related]  

  • 43. Direct labelling of ipratropium bromide aerosol and its deposition pattern in normal subjects and patients with chronic bronchitis.
    Spiro SG; Singh CA; Tolfree SE; Partridge MR; Short MD
    Thorax; 1984 Jun; 39(6):432-5. PubMed ID: 6235619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dose effects of inhaled ipratropium bromide on the impedance of the respiratory system in normal subjects.
    Wesseling GJ; Vonk JM; Greve LH; Wouters EF
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):33-8. PubMed ID: 2137435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of ipratropium bromide and fenoterol in asthma and chronic bronchitis.
    Marlin GE; Bush DE; Berend N
    Br J Clin Pharmacol; 1978 Dec; 6(6):547-9. PubMed ID: 153146
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunological release of histamine from human lung. II. Studies on acetylcholine and the anticholinergic agent ipratropium bromide.
    Morr H
    Respiration; 1979; 38(5):273-9. PubMed ID: 161410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of the effects on ventilatory function of a single administration of an ipratropium bromide-fenoterol combination in comparison with fenoterol alone].
    Ciaccia A; Castelletti ML; Soligo M
    Arch Monaldi; 1983; 38(5-6):255-62. PubMed ID: 6238580
    [No Abstract]   [Full Text] [Related]  

  • 48. Patterns of response to inhaled bronchodilators in asthmatics.
    Paré PD; Lawson LM; Brooks LA
    Am Rev Respir Dis; 1983 Jun; 127(6):680-5. PubMed ID: 6222679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Double inhalation test with ipratropium bromide and salbutamol--assessment of its effects on partial and maximum expiratory flow-volume curves].
    Kamio Y; Shibayama M; Kawai K; Futamata H; Matsubara F; Kanamori K; Uotani K; Okafuji K; Fujimura M; Koshino T
    Rinsho Byori; 1985 Nov; 33(11):1313-8. PubMed ID: 2869163
    [No Abstract]   [Full Text] [Related]  

  • 50. Aerosol Sch 1000. An anticholinergic bronchodilator.
    Storms WW; DoPico GA; Reed CE
    Am Rev Respir Dis; 1975 Apr; 111(4):419-22. PubMed ID: 123712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative study of the bronchodilating action of fenoterol and ipratropium bromide administered by aerosols in acute attacks of asthma].
    Della Toffola A; Ardizzi A; Giorgis GE; Galietti F; Massaglia GM; Onoscuri E
    Minerva Med; 1986 May; 77(22-23):1005-8. PubMed ID: 2941697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of terfenadine and ipratropium bromide on ultrasonically nebulized distilled water-induced asthma.
    Azevedo M; da Costa JT; Fontes P; da Silva JP; Araujo O
    J Int Med Res; 1990; 18(1):37-49. PubMed ID: 2139858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of ipratropium bromide and an oral anticholinergic drug in chronic bronchitis.
    Otto AJ
    Scand J Respir Dis Suppl; 1979; 103():151-3. PubMed ID: 155290
    [No Abstract]   [Full Text] [Related]  

  • 54. Hemodynamic effects of inhaled ipratropium bromide, alone and combined with an inhaled beta 2-agonist.
    Chapman KR; Smith DL; Rebuck AS; Leenen FH
    Am Rev Respir Dis; 1985 Oct; 132(4):845-7. PubMed ID: 2864891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.
    Thiessen B; Pedersen OF
    Respiration; 1982; 43(4):304-16. PubMed ID: 6213991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bronchoconstriction by nebulized metabisulfite solutions (SO2) and its modification by ipratropium bromide.
    Seale JP; Temple DM; Tennant CM
    Ann Allergy; 1988 Sep; 61(3):209-13. PubMed ID: 2970816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Vagal component in bronchial constriction induced by histamine: effect of ipratropium bromide].
    Lisboa C; Cruz E; Moreno R; Barja S; Flores GR; Guzmán MA
    Rev Med Chil; 1985 Nov; 113(11):1059-64. PubMed ID: 2942996
    [No Abstract]   [Full Text] [Related]  

  • 58. [Broncho-dilating effects of SCH 1000 in patients with spasmodic chronic bronchitis].
    Weitzenblum E; Rasaholinjanahary J
    Poumon Coeur; 1977; 33(4):219-24. PubMed ID: 144268
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hemodynamic effects of ipratropium bromide in comparison with atrial stimulation].
    Bergbauer M; Nebel W; Schneider M; Sabin G
    Arzneimittelforschung; 1983; 33(7):977-9. PubMed ID: 6226295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies.
    Simonsson BG
    Scand J Respir Dis Suppl; 1979; 103():130-42. PubMed ID: 155288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.